| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2019 | Healy James | Director | Sell | 360,000 | $22.30 | $8,027,600.00 | -8.2% | |
| Jun 20, 2019 | Healy James | Director | Sell | 317,130 | $21.37 | $6,777,068.10 | -12.1% | |
| Jun 19, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 6,826 | $19.85 | $135,513.62 | -12.7% | |
| May 30, 2019 | Lanfear Dennis M | President &CEO | Sell | 32,398 | $19.49 | $631,281.51 | -2.5% | |
| May 22, 2019 | Healy James | Director | Sell | 257,870 | $20.69 | $5,335,330.30 | -9.0% | |
| Mar 20, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sell | 3,000 | $14.92 | $44,762.10 | -18.5% | |
| Sep 10, 2018 | Finck Barbara K | Chief Medical Officer | Sale+OE | 1,760 | $18.58 | $32,698.86 | -4.5% | |
| Aug 29, 2018 | Healy James | Director | Sell | 25,000 | $20.50 | $512,500.00 | -0.9% | |
| Aug 13, 2018 | Finck Barbara K | Chief Medical Officer | Sale+OE | 1,760 | $19.02 | $33,479.95 | -4.5% | |
| Jul 23, 2018 | Viret Jean-Frederic | Chief Financial Officer | Sell | 9,291 | $18.56 | $172,471.62 | -71.1% |